REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Polskie Towarzystwo Immunologii Doswiadczalnej I Klinicznej (Poland)

Main Activities: Periodical Publishers
Secondary Activities: Tire Manufacturing
Full name: Polskie Towarzystwo Immunologii Doswiadczalnej I Klinicznej Profile Updated: July 24, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Polskie Towarzystwo Immunologii Doswiadczalnej I Klinicznej is an enterprise in Poland, with the main office in Poznan. The company operates in the Periodical Publishers industry. It was incorporated on November 24, 2003. The company’s latest financial report indicates a net sales revenue increase of 137.56% in 2023. A growth of 64.9% was recorded in its total assets.

Headquarters
Ul. Boznicza 2/36
Poznan; Wielkopolskie; Postal Code: 61-751

Contact Details: Purchase the Polskie Towarzystwo Immunologii Doswiadczalnej I Klinicznej report to view the information.

Basic Information
Outstanding Shares:
Purchase the Polskie Towarzystwo Immunologii Doswiadczalnej I Klinicznej report to view the information.
Incorporation Date:
November 24, 2003
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Management Board Member
Company Performance
Financial values in the chart are available after Polskie Towarzystwo Immunologii Doswiadczalnej I Klinicznej report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
137.56%▲
Total operating revenue
137.56%▲
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
N/A
Total assets
64.9%▲
Total equity
82.63%▲
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
14.59%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo